Abstract
Thalidomide in combination with chemotherapy does not improve survival of patients with small cell lung cancer, but is associated with an increase in the risk of thrombotic events.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Nursing standard (Royal College of Nursing (Great Britain) : 1987)
Paper Title
Journal
Date
